NEBNext Direct® offers a novel approach to NGS Target Enrichment. Using a unique, capture-based protocol, NEBNext Direct offers a range of solutions for highly specific, efficient targeting of genomic loci of interest. Optimized, 1-day protocols allow for rapid profiling of targeted regions for a variety of applications, including germline and somatic variant calling for translational research and genotyping of genomic markers for applications in agricultural biology and sample identification.
Choose from our predefined content panels, including the NEBNext Direct Cancer HotSpot Panel and NEBNext Direct BRCA1/ BRCA2 Panel, or define your own targeted sequencing panel by selecting only the genes you want from our expansive list of genes using NEBNext Direct Custom Ready Panels. For genotyping applications, the NEBNext Genotyping Solution enables pre-capture pooling of up to 96 samples for cost-effective and scalable genotyping of up to 5,000 genomic markers.
View our tutorial for help visualizing NEBNext Direct’s unique and enabling workflow.
Precision medicine requires precision enrichment. Learn more about target enrichment and its role in clinical applications.
Learn about the innovative NEBNext Direct technology for target enrichment for next generation sequencing.
- New! NEBNext Direct Genotyping Solution
- Configure your own NEBNext Direct Custom Ready Panel
- Pre-configured Panels
White paper available: Overcoming the challenges of applying target enrichment for translational research
For more information, please contact [email protected].
Try NEBNext Direct®
Request a sample
- Choose from a single gene to hundreds of genes
- Experience unmatched specificity and coverage uniformity
- Eliminate synthesis and optimization steps for faster turnaround
- Improve sensitivity with our Unique Molecular Identifier (UMI)
- Generate results in one day with our automation-friendly workflow
NEW ENGLAND BIOLABS® and NEB® are registered trademarks of New England Biolabs, Inc.
NEBNext Direct® is a trademark of New England Biolabs, Inc.
Directed Genomics™ is a trademark of Directed Genomics